Yi J, Thomas LM, Musayev FN, Safo MK, Richter-Addo GB
Meet our doctors Last reviewed: 19 Jun 2026 Sources Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity, Diabetes, Obesity and Metabolism, [accessed 14 January 2026] Transdermal drug delivery: overcoming the skin's barrier function, Europe PMC [accessed 14 January 2026] (D) Routes of delivery: Case studies: (6) Transdermal delivery of peptides and proteins, Advanced Drug Delivery Reviews, [accessed 14 January 2026] Semaglutide for the treatment of overweight and obesity: A review, Diabetes, Obesity and Metabolism, [accessed 14 January 2026] Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK, [accessed 14 January 2026]
Moderate Exercise: While intense overtraining can actually increase oxidative stress, regular, moderate exercise helps the body become more efficient at producing its own antioxidants
The controlled release of DNAzymes, the maximal cytocompatibility, and significantly improved BBB permeability suggest that our DNZ-NLPs offer a promising formulation for delivering all types of oligonucleotides to the brain for neurodegenerative disease treatments
CJC-1295 for growth hormone support CJC-1295 is a growth hormone-releasing hormone (GHRH) analogue that can stimulate the release of growth hormone from the pituitary
Liu X, Lin J, Zhang H, Khan NU, Zhang J, Tang X, et al